(Q47916260)

English

Meldonium decreases the diet-increased plasma levels of trimethylamine N-oxide, a metabolite associated with atherosclerosis

scientific article published on 25 July 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23893520

Meldonium decreases the diet-increased plasma levels of trimethylamine N-oxide, a metabolite associated with atherosclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23893520

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

Maija Dambrova

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23893520

Elina Skapare-Makarova

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23893520

Ilze Konrade

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23893520

Osvalds Pugovics

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23893520

Solveiga Grinberga

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23893520

Dace Tirzite

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23893520

Ramona Petrovska

7

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23893520

Ivars Kalvins

8

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23893520

Edgars Liepins

9

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23893520

publication date

25 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23893520

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23893520

53

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23893520

10

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23893520

1095-1098

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23893520

Mildronate: cardioprotective action through carnitine-lowering effect

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.135

21 January 2018

The cardioprotective effect of mildronate is diminished after co-treatment with L-carnitine

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.135

21 January 2018

Mildronate treatment alters γ-butyrobetaine and l-carnitine concentrations in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.135

21 January 2018

3-(2,2,2-Trimethylhydrazinium)propionate (THP)--a novel gamma-butyrobetaine hydroxylase inhibitor with cardioprotective properties

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.135

21 January 2018

Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.135

21 January 2018

Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.135

21 January 2018

Disposition and metabolite kinetics of oral L-carnitine in humans

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.135

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.135

21 January 2018

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.135

21 January 2018

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.135

21 January 2018

Use of mass spectrometry fingerprinting to identify urinary metabolites after consumption of specific foods

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.135

21 January 2018

Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.135

21 January 2018

Mildronate, a regulator of energy metabolism, reduces atherosclerosis in apoE/LDLR-/- mice

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.135

21 January 2018

Identifiers

10.1002/JCPH.135

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23893520

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23893520

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47916260&oldid=2175695080"